 
                                                                             
                                        
                                        As the pharmaceutical industry increasingly turns to CMOs for flexibility, specialised expertise, and scalable capacity, challenges often emerge around timelines, regulatory requirements, and quality expectations. These misalignments can hinder collaboration and limit the strategic value that CMOs bring.
The purpose of this interactive session is to co-create a practical benchmark framework that both CMOs and pharma companies can use to drive stronger partnerships. By defining shared standards, performance metrics, and realistic expectations, the aim is to move beyond transactional outsourcing and position CMOs as true strategic partners in the value chain.
In this session, CMOs and pharma representatives will work together to:
Check out the incredible speaker line-up to see who will be joining Carlo.
Download The Latest Agenda